This inventor holds 3 USPTO granted patents. Top assignee: Sigilon Therapeutics, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Innovations by Guillaume Carmona
Introduction
Guillaume Carmona is a notable inventor based in Cambridge, France. He has made significant contributions to the field of biotechnology, particularly in the treatment of rare diseases. With a focus on innovative solutions, he has been awarded 3 patents for his groundbreaking work.
Latest Patents
Carmona's latest patents include "Compositions, Devices, and Methods for Treating Fabry Disease" and "Monoclonal Cell Lines Expressing an Exogenous Substance and Uses Thereof." These patents reflect his commitment to advancing medical treatments and improving patient outcomes.
Career Highlights
Guillaume Carmona is currently associated with Sigilon Therapeutics, Inc., where he continues to develop innovative therapies. His work is instrumental in the ongoing research and development of treatments for genetic disorders.
Collaborations
Carmona collaborates with talented professionals in his field, including Lauren Emily Barney and Marianthi Papakosta. These partnerships enhance the research efforts and contribute to the success of their projects.
Conclusion
Guillaume Carmona's contributions to biotechnology and his innovative patents demonstrate his dedication to improving healthcare solutions. His work continues to inspire advancements in the treatment of rare diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile